Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

Stroke

Volumn 38, Issue 9, 2007, Pages 2526-2530

  Kunte, Hagen ^a   Schmidt, Sein ^a   Eliasziw, Michael ^b   Del Zoppo, Gregory J ^c   Simard, J Marc ^d,f   Masuhr, Florian ^a   Weih, Markus ^e   Dirnagl, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f Department of Neurosurgery ^*  (United States)

Author keywords

Cerebral ischemia; Diabetes mellitus; Glibenclamide; Stroke; Sulfonylurea

Indexed keywords

GLIBENCLAMIDE; GLIBORNURIDE; GLIMEPIRIDE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; MALE; PATIENT SELECTION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 34547673319     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.482216     Document Type: Article

References (26)

1. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64:654-659.
2. Chen M, Simard JM. Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain. J Neurosci. 2001;21:6512-6521.
3. Chen M, Dong Y, Simard JM. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci. 2003;23:8568-8577.
4. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433-440.
5. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258-268.
6. Weih M, Amberger N, Wegener S, Dirnagl U, Reuter T, Einhaupl K. Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes. Stroke. 2001;32:2029-2032.
7. Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol. 1999;61:337-362.
8. Nakahata K, Kinoshita H, Hirano Y, Kimoto Y, Iranami H, Hatano Y. Mild hypercapnia induces vasodilation via adenosine triphosphate-sensitive K+ channels in parenchymal microvessels of the rat cerebral cortex. Anesthesiology. 2003;99:1333-1339.
9. Reid JM, Davies AG, Ashcroft FM, Paterson DJ. Effect of L-NMMA, cromakalim, and glibenclamide on cerebral blood flow in hypercapnia and hypoxia. Am J Physiol. 1995;269:H916-H922.
10. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
11. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
12. de Haan R, Limburg M, Bossuyt P, van der MJ, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke. 1995;26:2027-2030.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
14. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31:1062-1068.
15. Arboix A, Milian M, Oliveres M, Garcia-Eroles L, Massons J. Impact of female gender on prognosis in type 2 diabetic patients with ischemic stroke. Eur Neurol. 2006;56:6-12.
16. Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, Davalos A. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol. 2003;54:811-819.
17. Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, Einhaupl KM. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke. 1999;30:1851-1854.
18. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2007;27:435-451.
19. Bruno A, Williams LS, Kent TA. How important is hyperglycemia during acute brain infarction? Neurologist. 2004;10:195-200.
20. Shook SJ, Gupta R, Vora NA, Tievsky AL, Katzan I, Krieger DW. Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging. 2006;16:341-346.
21. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA. 1998;279:1265-1272.
22. Kurukulasuriya LR, Govindarajan G, Sowers J. Stroke prevention in diabetes and obesity. Exp Rev Cardiovasc Ther. 2006;4:487-502.
23. Arboix A, Rivas A, Garcia-Eroles L, de Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol. 2005;5:9.
24. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg. 2004;101:664-668.
25. Bayerle-Eder M, Wolzt M, Polska E, Langenberger H, Pleiner J, Teherani D, Rainer G, Polak K, Eichler HG, Schmetterer L. Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1667-R1673.
26. Mayhan WG. Effect of diabetes mellitus on response of the basilar artery to activation of ATP-sensitive potassium channels. Brain Res. 1994;636:35-39.